CEO, ODS Medical
Chris has served as the CEO of ODS Medical since its’ founding in 2015. ODS Medical is commercializing an unique Raman spectroscopy system for real-time, intra-operative tissue characterization during surgery. Prior to ODS Medical, he worked with Dr. Kevin Petrecca, building a translational research program at the Montreal Neurological Institute focused on working with industry partners to accelerate the discovery and pre-clinical development of treatments for brain cancers. He also did his PhD at McGill in Neuroscience and has published numerous peer-reviewed journal articles.